WINSTON-SALEM, NC -- (Marketwired) -- 05/05/14 -- Clinical Ink, an innovation-driven eSource solutions company, today announced that it has been selected as a finalist for the 2014 Red Herring Top 100 North America award, a prestigious list honoring the year's most promising private technology ventures from North America. Clinical Ink was deemed a finalist based on its technological innovation, management strength, market size, investors record, customer acquisition and financial health.
"Being recognized among the top innovators throughout North America is, indeed, a significant honor," said Ed Seguine, CEO of Clinical Ink. "This initial recognition is further evidence of the transformative impact our business model is having on the conduct of clinical research and validates our early success in establishing a new technology/services market."
Clinical Ink's SureSource® platform, the first purpose-built integrated eSource solution, eliminates paper documents in clinical research to dramatically reduce the time and cost of clinical trials. Bridging the "document-data" divide, the SureSource platform is an integrated solution for easy implementation of eSource in clinical trials -- from study start to regulatory submission. Sponsors reduce the cost and duration of clinical research by eliminating Source Data Verification; reducing data queries, minimizing monitoring time, and facilitating risk-based monitoring -- all without disrupting back-end data management/analysis activities.
"The finalists list confirms the excellent choices made by entrepreneurs and venture capitalists, and the start-ups' solid roots in corporate America, embracing their innovations," said Alex Vieux, Publisher and CEO of Red Herring. "By all metrics, the Red Herring Top 100 finalists emphasize U.S. entrepreneurial excellence."
As a finalist, Clinical Ink will present at the Red Herring North America Forum in Monterey, Ca. from May 14-16, 2014. The Top 100 winners will be announced at a special awards ceremony on May 16, 2014. Since 2011, Clinical Ink has won six industry awards from various corporations, industry organization and media outlets, including Microsoft, Gartner and the Society of Clinical Data Management.
About Clinical Ink
With offices in Winston-Salem, NC and Philadelphia, PA, Clinical Ink is an innovation-driven eSource solutions company committed to delivering technology that makes clinical research easier for sites, sponsors, subjects and regulators. Developers of SureSource®, the first purpose-built integrated eSource platform providing cleaner data faster, Clinical Ink is dedicated to eliminating paper documents in clinical research. Additional information about Clinical Ink is available at www.clinicalink.com or by calling toll-free 800-301-5033.